A research study testing the safety and tolerability of a new medication, WIN027, which is being developed to treat moderate-to-severe asthma and chronic obstructive pulmonary disease (COPD) in healthy adult volunteers
Status: Not Yet Recruiting —
Phase: Phase 1
— Start:
A Clinical Study Evaluating Whether PRA-216 Injections are Safe and Effective for People with Moderate to Severe Eczema (Atopic Dermatitis) That Has Not Been Well Controlled by Standard Treatments
A clinical trial investigating whether a botulinum toxin (Botox) nasal spray can help people with rhinitis (runny or blocked nose) that has not improved with standard treatments
Status: Not Yet Recruiting —
Phase: Phase 2
— Start:
Comparing two ways to start bee venom allergy treatment: beginning straight at the full maintenance dose versus a rapid step-up approach completed in one day
Status: Not Yet Recruiting —
Phase: Phase 0
— Start:
Evaluating the Chronic Conditions Course for Young Adults (CCC-YA): An internet-delivered CBT program to improve wellbeing in young adults living with chronic illness
Status: Not Yet Recruiting —
Phase: Not Applicable
— Start:
Conditions: Various chronic physical health conditions/diseases, Anxiety, Depression, Diabetes, Chronic pain, Arthritis and other musculoskeletal conditions, Inflammatory bowel disease, Asthma, Migraine, Endometriosis, PCOS
A study testing the safety and effectiveness of an investigational drug called S-4321 in people with autoimmune conditions like rheumatoid arthritis, psoriatic arthritis, psoriasis, lupus, or atopic dermatitis
A first-in-human safety study testing an investigational injection treatment (UKK-0018) designed to help adults with peanut allergies better tolerate accidental peanut exposure